Search

everythinglearnresearchcommunity

for

Search:↓

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

The conclusion is that accurately identifying folliculosebaceous tumors requires understanding their clinical signs and microscopic features.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

The document concludes that early diagnosis and treatment are crucial for managing skin diseases in ferrets.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Androgen and Wnt signals are crucial for developing and functioning male genitalia and erectile tissues.

Clascoterone may be a promising treatment for hair loss.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

Finasteride and metformin both help treat PCOS, but using them together works best.

Testosterone may worsen hair loss by affecting hair growth signals, while different prostaglandins can either hinder or promote hair growth.

Paxillin may help manage androgen-related disorders like PCOS by stabilizing androgen receptor proteins.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

The method accurately measures seven androgens in plasma and shows different hormone levels in females with acne and obesity.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Hair loss in men can be slowed or reversed with treatments like minoxidil and finasteride, but it resumes if treatment stops. It may also indicate early heart disease and obesity.

Aging men face unique health issues like erectile dysfunction, prostate problems, and baldness.